Konstantin von Unger
Member Shareholder Committee @ Henkel
London, United Kingdom
Konstantin von Unger is a an experienced investor in technology companies and an independent Board member. He serves as the Vice Chairman of the Shareholders' Committee at Henkel AG and as the Chairman of the supervisory board at the Henkel Family Office. Konstantin attended London Business School and Brown University.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Konstantin von Unger invests in
Stages Konstantin von Unger invests in
Countries Konstantin von Unger invests in
Round sizes
Round size
- Seed
- $1.5M–$8.7M
- Series A
- $5.5M–$10M
- Series D
- $13M–$90M
Investment Focus
Industry
- Software 14 (42%)
- SaaS 6 (18%)
- Machine Learning 6 (18%)
- Artificial Intelligence 6 (18%)
- Analytics 4 (12%)
Stage
- Seed 11 (33%)
- Series A 6 (18%)
- Series D 3 (9%)
- Convertible Note 3 (9%)
- Pre-Seed 2 (6%)
Country
- United States 22 (67%)
- Germany 2 (6%)
- United Kingdom 2 (6%)
- India 1 (3%)
- Poland 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Anzen Industries
|
Anzen Industries focuses on biotech innovation, engineering molecular resilience by stabilizing enzymes for industrial reactions. | $2.3M / Pre-Seed / Jan 19, 2026 | |
NobleAI
|
NobleAI’s commercially proven Science-Based AI technology enables companies to reduce the cost and accelerate the development of better performing, more environmentally sustainable and reliably sourced chemical & material products. | Convertible Note / Jun 24, 2022 | |
Arda Therapeutics
|
Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA. | Seed / Dec 17, 2021 | |
Valdera
|
Valdera is a software that provides automatic outreach, sales generation, and custom specification services for buyers and suppliers. | Seed / Oct 06, 2021 | |
Fero Labs
|
Fero Labs is an actionable machine learning software for improving processes and increasing the quality of manufacturing facilities. Fero Labs prides itself on increasing factories’ profits by combining their existing data with the latest advances in the field of data science. By utilizing Fero, the automated machine learning software, Fero Labs’customers understand the root causes of the problems leading to process and quality issues. Armed with new insights into their production, factories resolve the underlying issues leading to continuous process improvement.It was founded in 2015 and headquartered in New York, United States. | $9M / Series A / Jul 21, 2021 | |
|
Fero Labs
|
Fero Labs is an actionable machine learning software for improving processes and increasing the quality of manufacturing facilities. Fero Labs prides itself on increasing factories’ profits by combining their existing data with the latest advances in the field of data science. By utilizing Fero, the automated machine learning software, Fero Labs’customers understand the root causes of the problems leading to process and quality issues. Armed with new insights into their production, factories resolve the underlying issues leading to continuous process improvement.It was founded in 2015 and headquartered in New York, United States. | Series A / Mar 31, 2021 | |
SmithRx
|
SmithRx is a pharmacy benefits partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product.A San Francisco-based technology company, SmithRx was founded in2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single technology platform, concierge-level service, and strong drug cost, rebate, and service level guarantees. The in-house team brings together experience from healthcare companies including Anthem, Collective Health, and Castlight Health, as well as a broader set of technology leaders including Facebook, LinkedIn, Glassdoor, and Docker. Front-line clinicians guide plan execution and member support.Named after a smith, a craftsman, or someone who is precise about their trade. SmithRx embodies these characteristics and brings precision to the pharmacy benefits industry by leveraging technology and data to forge the product of the future. | Series A / Jan 03, 2021 | |
Flip
|
Flip is the employee app empowering all employees from firstline to desktop. It does so by combining top-down and bottom-up communication tools such as newsfeed and chat with intuitive integrations in the existing corporate HR and IT landscape. Flip empowers employers by enabling them to reach all employees at the same time with just two clicks.The company was founded in 2018 and is based in Stuttgart, Germany. | Series A / Jan 01, 2021 | |
Airly
|
Airly empowers individuals and communities with knowledge about the air they breathe. Airly is changing the way people see the air they breathe by providing accurate, hyper-local data about air pollution. | $2M / Pre-Seed / Oct 02, 2020 | |
Octane AI
|
Trusted by 1,000+ Shopify and Shopify plus brands, Octane AI provides an all-in-one platform for engaging quizzes, data collection, and personalized Facebook Messenger and SMS automation. Merchants use Octane AI to connect, convert, and retain customers by personalizing the customer journey and giving customers the confidence to purchase.OctaneAI is backed by top Silicon Valley investors, including Bullpen Capital, General Catalyst, FJLabs, M Ventures, and the founders of Hipmunk, Hearsay Systems, and Articulate. The company is all-remote and employs team members in 10+ countries. It was founded in 2016 by Matt Schlicht, Ben Parr, and Leif K-Brooks. | Seed / Dec 20, 2019 | |
| See all 33 investments → | |||
Co-Investors
About Henkel
Henkel was founded in 1876. People around the world trust Henkel’s brands and technologies. In the fiscal year 2015, the company reported sales of approx. 18 billion euros and an operating profit of 2.9 billion euros (adjusted for one-time gains/charges and restructuring charges). The DAX-30 company has its headquarters in Düsseldorf, Germany.Henkel employs about 50,000 people worldwide, more than 80 percent of whom work outside of Germany. Henkel is thus one of the most international German companies
Henkel Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Esther Kumpan-Bahrami
Corporate Director Digital Marketing International
|
|||
Gesa Geissel
Head of Digital Marketing Brands & Campaigns bei Henkel
|
|||
Nils Daecke
Corporate Vice President Business Development & Digital Marketing at Henkel
|
|||
Rik Strubel
Chief Marketing Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Konstantin von Unger invest in?
Konstantin von Unger invests primarily in Software, SaaS and Machine Learning startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Konstantin von Unger's check size?
Konstantin von Unger typically joins rounds of $1.5M–$8.7M at Seed, $5.5M–$10M at Series A and $13M–$90M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Konstantin von Unger participates in.
When did Konstantin von Unger last invest?
The most recent investment recorded for Konstantin von Unger closed in Jan 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
